JP2018528759A5 - - Google Patents

Download PDF

Info

Publication number
JP2018528759A5
JP2018528759A5 JP2017567294A JP2017567294A JP2018528759A5 JP 2018528759 A5 JP2018528759 A5 JP 2018528759A5 JP 2017567294 A JP2017567294 A JP 2017567294A JP 2017567294 A JP2017567294 A JP 2017567294A JP 2018528759 A5 JP2018528759 A5 JP 2018528759A5
Authority
JP
Japan
Prior art keywords
amino acid
cdr
seq
acid sequence
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017567294A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018528759A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/040183 external-priority patent/WO2017004254A1/en
Publication of JP2018528759A publication Critical patent/JP2018528759A/ja
Publication of JP2018528759A5 publication Critical patent/JP2018528759A5/ja
Pending legal-status Critical Current

Links

JP2017567294A 2015-06-30 2016-06-29 抗血管内皮増殖因子受容体2(vegfr2)抗体 Pending JP2018528759A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562187204P 2015-06-30 2015-06-30
US62/187,204 2015-06-30
PCT/US2016/040183 WO2017004254A1 (en) 2015-06-30 2016-06-29 Anti-vascular endothelial growth factor receptor 2 (vegfr2) antibodies

Publications (2)

Publication Number Publication Date
JP2018528759A JP2018528759A (ja) 2018-10-04
JP2018528759A5 true JP2018528759A5 (enExample) 2019-08-08

Family

ID=57609558

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017567294A Pending JP2018528759A (ja) 2015-06-30 2016-06-29 抗血管内皮増殖因子受容体2(vegfr2)抗体

Country Status (12)

Country Link
US (1) US20180193456A1 (enExample)
EP (1) EP3316908A4 (enExample)
JP (1) JP2018528759A (enExample)
KR (1) KR20180021136A (enExample)
CN (1) CN108025067A (enExample)
AU (1) AU2016288192A1 (enExample)
BR (1) BR112017027702A2 (enExample)
CA (1) CA2990450A1 (enExample)
HK (1) HK1254048A1 (enExample)
RU (1) RU2018103192A (enExample)
TW (1) TW201718641A (enExample)
WO (1) WO2017004254A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017117384A1 (en) 2015-12-31 2017-07-06 Development Center For Biotechnology Anti-vegfr antibody and uses thereof
CN106674349B (zh) * 2017-03-07 2018-03-13 北京东方百泰生物科技有限公司 一种改进的抗vegfr‑2单克隆抗体
TWI665213B (zh) * 2017-06-29 2019-07-11 財團法人生物技術開發中心 抗人類血管內皮生長因子受體之抗體及其應用
US11623960B2 (en) 2018-03-20 2023-04-11 National Health Research Institutes Dual-function antibodies targeting VEGFR2 and VEGFR3
WO2021013061A1 (zh) * 2019-07-19 2021-01-28 神州细胞工程有限公司 一种人源化抗vegfr2抗体及其应用
JP2024500847A (ja) 2020-12-18 2024-01-10 センチュリー セラピューティクス,インコーポレイテッド 適合可能な受容体特異性を有するキメラ抗原受容体システム
CN113480653B (zh) * 2021-08-06 2022-05-06 朱有建 一种含有γδT细胞的药物组合物在治疗癌症中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119130B2 (en) * 2007-07-25 2012-02-21 Medimmune Limited Targeted binding agents directed to KDR and uses thereof—035
EP2215121B1 (en) * 2007-11-26 2016-02-10 Bayer Intellectual Property GmbH Anti-mesothelin antibodies and uses therefor
US8128932B2 (en) * 2009-08-17 2012-03-06 Shanghai Aosaiersi Biotech Co., Ltd. Anti-VEGFR monoclonal antibody, method of making and uses thereof
US9029510B2 (en) * 2012-03-30 2015-05-12 Sorrento Therapeutics, Inc. Fully human antibodies that bind to VEGFR2 and methods of use thereof
CN116003600A (zh) * 2012-10-05 2023-04-25 卡德门企业有限公司 人抗vegfr-2/kdr抗体

Similar Documents

Publication Publication Date Title
JP2018528759A5 (enExample)
JP2017521054A5 (enExample)
JP2020501598A5 (enExample)
JP2019535254A5 (ja) 抗pd−l1抗体および変異型
RU2017122014A (ru) Антитела к c10orf54 и их применения
JP2017535257A5 (enExample)
JP2020534830A5 (enExample)
US11970529B2 (en) Protein binding to fibronectin B domain
JP2013056885A5 (enExample)
JP6875275B2 (ja) L1cam(cd17)と結合する抗体などの結合分子
CN118388647A (zh) 一种分离的Claudin18.2抗体及其应用
JP2013502913A5 (enExample)
JP2011207882A5 (enExample)
CN105209493A (zh) 用于诊断和治疗用途的her3特异性单克隆抗体
HRP20192038T1 (hr) Protutijela receptora anti-epidermalnog faktora rasta (egfr)
RU2019107134A (ru) Анти-pd-1 антитела
JP2013534515A5 (ja) 受容体型チロシンキナーゼc−Metに対する抗体
RU2009123409A (ru) Новые антипролиферативные антитела
JP2010509931A5 (enExample)
JP2020534012A5 (enExample)
JP2020522488A5 (enExample)
RU2018103192A (ru) Антитела против рецептора 2 фактора роста эндотелия сосудов (vegfr2)
JP7711208B2 (ja) Dll3に対する結合分子及びその使用
JP2009544574A5 (enExample)
CN114786720A (zh) TriAx抗体的组合物及其制备和使用方法